Weekly News Recap #Phispers
Mallinckrodt, Endo merge in US$ 6.7 bn deal; Astra buys cell therapy developer EsoBiotec; Pfizer sells entire stake in Haleon

Mallinckrodt, Endo merge in US$ 6.7 bn deal; Astra buys cell therapy developer EsoBiotec; Pfizer sells entire stake in Haleon

In Phispers this week, two drugmakers emerging from bankruptcy — Mallinckrodt and Endo — are merging in order to le...

Impressions : 1329

2020 begins with drug price increases in US and mysterious illness in China

This week in Phispers, we have news about pharmaceutical companies ushering in the new year with a hike in US list prices of ov...

Impressions : 2771

FDA Updates List of Drugs with No Patents & No Competition; Approves First Marijuana Based Drug

This week Phispers has lots of news from the FDA. While the Trump administration announced its plans to reduce the jurisdicti...

Impressions : 5350

2017 closes with record approvals of generics, novel drugs; 2018 begins with reprieves for Teva

PharmaCompass wishes its readers a very happy new year. We begin the year with an analysis of 2017, when we saw record approval...

Impressions : 4361